NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Thomas, Remy, Al-Khadairi, Ghaneya, Roelands, Jessica, Hendrickx, Wouter, Dermime, Said, Bedognetti, Davide, Decock, Julie
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941317/
https://ncbi.nlm.nih.gov/pubmed/29770138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00947
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados